Breakthroughs and challenges in the management of tropomyosin receptor kinase fusion-positive tumors. [PDF]
The past decade has witnessed a paradigm shift in the treatment of cancer, moving from ‘one size fits all’ to a more precision medicine-based approach owing to the development of molecular diagnostic technologies capable of identifying an increasing number of actionable genomic alterations in the tumor tissue and circulating tumor DNA.
Mamdani H, Jalal SI.
europepmc +4 more sources
A tropomyosin-receptor kinase-fused gene mutation associates with vacuolar myopathy. [PDF]
A 44-year-old Caucasian man presented with a 7-year history of upper and lower limb muscle fasciculations and cramps, progressive asymmetric weakness, muscle atrophy, and length-dependent sensory loss. His parents (deceased), 3 older siblings, and 3 children had no history of neurologic symptoms, including weakness and sensory symptoms, with the ...
Madigan NN+6 more
europepmc +5 more sources
Survival Outcomes of Patients With Tropomyosin Receptor Kinase Fusion-Positive Cancer Receiving Larotrectinib Versus Standard of Care: A Matching-Adjusted Indirect Comparison Using Real-World Data. [PDF]
Bokemeyer C+7 more
europepmc +3 more sources
Nerve growth factor and Tropomyosin receptor kinase A are increased in the gastric mucosa of patients with functional dyspepsia [PDF]
Background Nerve growth factor (NGF) and enteric glial cells (EGCs) are associated with visceral hypersensitivity and gastrointestinal motility disorder, which may represent the pathogenesis of functional dyspepsia (FD).
Haitao Shi+6 more
doaj +2 more sources
The Role of the Second Extracellular Loop of Norepinephrine Transporter, Neurotrophin-3 and Tropomyosin Receptor Kinase C in T Cells: A Peripheral Biomarker in the Etiology of Schizophrenia. [PDF]
Rodrigues-Amorim D+13 more
europepmc +3 more sources
Inhibition of Adult Hippocampal Neurogenesis Plays a Role in Sevoflurane-Induced Cognitive Impairment in Aged Mice Through Brain-Derived Neurotrophic Factor/Tyrosine Receptor Kinase B and Neurotrophin-3/Tropomyosin Receptor Kinase C Pathways. [PDF]
Xu L+8 more
europepmc +3 more sources
Beyond Clinical Trials: Understanding Neurotrophic Tropomyosin Receptor Kinase Inhibitor Challenges and Efficacy in Real-World Pediatric Oncology. [PDF]
Vince CSC+28 more
europepmc +3 more sources
Retraction: Yizhi Qingxin formula extract ameliorates cognitive decline in aged rats via the brain-derived neurotrophic factor/tropomyosin receptor kinase B pathway. [PDF]
Frontiers Editorial Office.
europepmc +2 more sources
The Research Progress of Neurotrophic Tyrosine Receptor Kinase (NTRK) Gene Fusions and Tropomyosin Receptor Kinase (TRK) Inhibitors: A Narrative Review [PDF]
Li J, Liang Y.
europepmc +2 more sources
CTNI-04. ACTIVITY OF LAROTRECTINIB IN TROPOMYOSIN RECEPTOR KINASE (TRK) FUSION CANCER PATIENTS WITH CENTRAL NERVOUS SYSTEM (CNS) METASTASES [PDF]
Patel J+11 more
europepmc +3 more sources